These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 13819448)

  • 1. The use of polysorbate 80-choline-inositol complex in the treatment of hypercholesteremia.
    EDWARDS RV
    J Fla Med Assoc; 1959 Nov; 46():565-71. PubMed ID: 13819448
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypercholesteremia; effect on cholesterol metabolism of a polysorbate 80-choline-inositol complex (monichol).
    SHERBER DA; LEVITES MM
    J Am Med Assoc; 1953 Jun; 152(8):682-6. PubMed ID: 13044609
    [No Abstract]   [Full Text] [Related]  

  • 3. Cholesterol metabolism; evaluation of polysorbate 80-choline-inositol complex (monichol) for the management of hypercholesteremia.
    ALBERT A; ALBERT M
    Tex State J Med; 1954 Dec; 50(12):814-8. PubMed ID: 13216699
    [No Abstract]   [Full Text] [Related]  

  • 4. Reduction of serum cholesterol in hypercholesteremic patients: effect of a polysorbate 80-choline-inositol complex.
    FULLER HL
    Md State Med J; 1959 Jan; 8(1):6-13. PubMed ID: 13612379
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypercholesteremia.
    BORDIN C
    Med Times; 1959 Jun; 87(6):787-91. PubMed ID: 13666226
    [No Abstract]   [Full Text] [Related]  

  • 6. [First trials in clinical dermatology and therapeutic indications for a polysorbate-lipotropic complex].
    GODAY PRATS A
    Rev Clin Esp; 1959 Jun; 73():415-20. PubMed ID: 13850334
    [No Abstract]   [Full Text] [Related]  

  • 7. Diphenylilethylacetic acid inhibits hypercholesteremia induced by triton.
    GARATTINI S; MORPURGO C; PASSERINI N
    Experientia; 1956 Sep; 12(9):347-8. PubMed ID: 13365594
    [No Abstract]   [Full Text] [Related]  

  • 8. Triton hypercholesteremia: cause or consequence of augmented cholesterol synthesis.
    BYERS SO; FIEDMAN M; SUGIYAMA T
    Am J Physiol; 1963 Jun; 204():1100-2. PubMed ID: 14017481
    [No Abstract]   [Full Text] [Related]  

  • 9. Polysorbates 20 and 80 used in the formulation of protein biotherapeutics: structure and degradation pathways.
    Kerwin BA
    J Pharm Sci; 2008 Aug; 97(8):2924-35. PubMed ID: 17973307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical and biophysical effects of polysorbate 20 and 80 on darbepoetin alfa.
    Deechongkit S; Wen J; Narhi LO; Jiang Y; Park SS; Kim J; Kerwin BA
    J Pharm Sci; 2009 Sep; 98(9):3200-17. PubMed ID: 19388064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of hypercholesteremia with beta-pyridylcarbinol. I. Biochemistry and clinical results].
    Zöllner N; Gudenzi M
    Med Klin; 1966 Dec; 61(50):1996-2001. PubMed ID: 5994695
    [No Abstract]   [Full Text] [Related]  

  • 12. [Various pharmacological aspects of polysorbate 80].
    VERGES C
    Rev Iber Endocrinol; 1959; 6():353-61. PubMed ID: 13841790
    [No Abstract]   [Full Text] [Related]  

  • 13. [Preliminary observations on the behavior of the pancreatic islets in rabbits fed a high cholesterol diet (with or without intravenous injections of tween 80)].
    D'Amore I; Papi F; Pescatori GF; Weber G
    Boll Soc Ital Biol Sper; 1973 Sep; 49(18):1019-21. PubMed ID: 4605870
    [No Abstract]   [Full Text] [Related]  

  • 14. [DRUGS LOWERING THE CHOLESTEROL LEVEL IN THE BLOOD].
    MARKIEWICZ M
    Pol Tyg Lek; 1963 Sep; 18():1412-6. PubMed ID: 14087059
    [No Abstract]   [Full Text] [Related]  

  • 15. HYPERLIPEMIC SERA IN THE RABBIT'S CORNEA.
    SILVER MD; WEIGENSBERG BI; MCMILLAN GC
    Arch Pathol; 1965 Aug; 80():171-6. PubMed ID: 14330337
    [No Abstract]   [Full Text] [Related]  

  • 16. Solubilization of salicylic acid by polysorbate 80 as determined by solubility titration.
    HALL NA
    J Pharm Sci; 1963 Feb; 52():189-91. PubMed ID: 13952124
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of Polysorbate 20 and Polysorbate 80 on the Higher-Order Structure of a Monoclonal Antibody and Its Fab and Fc Fragments Probed Using 2D Nuclear Magnetic Resonance Spectroscopy.
    Singh SM; Bandi S; Jones DNM; Mallela KMG
    J Pharm Sci; 2017 Dec; 106(12):3486-3498. PubMed ID: 28843351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lipotropic factors and atherosclerosis; action of methionine, choline and inositol on experimental cholesterol atherosclerosis].
    CAPRETTI G; PAGLIA G
    G Clin Med; 1950 Sep; 31(9):1120-37. PubMed ID: 14793721
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapy of hypercholesteremia].
    OCHEL HW; SCHROEDER H
    Dtsch Med J; 1956 Oct; 7(16):606-7. PubMed ID: 13384141
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of hypercholesteremia.
    MALMROS H; WIGAND G
    Minn Med; 1955 Dec; 38(12):864-70. PubMed ID: 13279888
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.